| Filed On | Filing |
|---|---|
| 18 Sep 2009 |
8-K/A: Financial Statements and Exhibits
You have requested our opinion with respect to certain matters in connection with the sale by Rigel Pharmaceuticals, Inc. (the “Company”), of up to 14,950,000 shares of the Company’s common stock, par value $0.001 per share (the “Shares”... |
| 14 Nov 2005 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On October 6, 2005, Rigel Pharmaceuticals, Inc. filed a Current Report on Form 8-K to report that Gary A. Lyons, was appointed to serve on Rigel’s Board of Directors. At the time of his appointment, the Board of Directors had not yet det... |
Loading...